It is time to end our love affair with short-acting β 2 -agonists in asthma.

Published in: ERJ open research (2022)

In this issue of ERJOR , Noorduyn et al. add data to the growing literature showing that SABA overuse in asthma is both common and associated with severe exacerbations. It is time to take note and act to tackle this global issue. https://bit.ly/3BfwhfS.

Keyphrases

chronic obstructive pulmonary disease
lung function
allergic rhinitis
cystic fibrosis
systematic review
big data
air pollution
data analysis